ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vintage
|
599 |
186K |
9 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
599
|
186K
|
9
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
vintage
|
2.4K |
1.1M |
11 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
11
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vintage
|
599 |
186K |
15 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
599
|
186K
|
15
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
vintage
|
803 |
272K |
7 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
803
|
272K
|
7
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
vintage
|
803 |
272K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
803
|
272K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
vintage
|
2.6K |
624K |
13 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
2.6K
|
624K
|
13
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vintage
|
176 |
49K |
2 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
176
|
49K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vintage
|
176 |
49K |
1 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
176
|
49K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
vintage
|
2.6K |
624K |
24 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
2.6K
|
624K
|
24
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vintage
|
176 |
49K |
2 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
176
|
49K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vintage
|
176 |
49K |
6 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
176
|
49K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vintage
|
176 |
49K |
7 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
176
|
49K
|
7
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vintage
|
176 |
49K |
7 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
176
|
49K
|
7
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vintage
|
176 |
49K |
12 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
176
|
49K
|
12
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vintage
|
176 |
49K |
12 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
176
|
49K
|
12
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vintage
|
176 |
49K |
9 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
176
|
49K
|
9
|
|
ASX - By Stock
|
DXB Medicine |
Re:
DXB Media thread.
|
|
vintage
|
125 |
47K |
8 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
125
|
47K
|
8
|
|
ASX - By Stock
|
DXB Medicine |
Re:
DXB Media thread.
|
|
vintage
|
125 |
47K |
2 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
125
|
47K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference
|
|
vintage
|
33 |
7.9K |
6 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
33
|
7.9K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference
|
|
vintage
|
33 |
7.9K |
8 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
33
|
7.9K
|
8
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
vintage
|
46 |
15K |
14 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
46
|
15K
|
14
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
vintage
|
46 |
15K |
12 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
46
|
15K
|
12
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vintage
|
153 |
41K |
6 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
153
|
41K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vintage
|
153 |
41K |
13 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
153
|
41K
|
13
|
|
ASX - By Stock
|
DXB |
Re:
$2
|
|
vintage
|
27 |
8.7K |
7 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
27
|
8.7K
|
7
|
|
ASX - By Stock
|
DXB |
Re:
$2
|
|
vintage
|
27 |
8.7K |
5 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
27
|
8.7K
|
5
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
vintage
|
2.4K |
1.1M |
3 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
3
|
|
ASX - By Stock
|
DXB |
Re:
$2
|
|
vintage
|
27 |
8.7K |
20 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
27
|
8.7K
|
20
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
vintage
|
2.4K |
1.1M |
14 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
14
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
vintage
|
2.4K |
1.1M |
11 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
11
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vintage
|
93 |
22K |
7 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
7
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
vintage
|
2.4K |
1.1M |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vintage
|
93 |
22K |
6 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vintage
|
93 |
22K |
3 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
vintage
|
2.4K |
1.1M |
7 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
7
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vintage
|
93 |
22K |
7 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
22K
|
7
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
vintage
|
2.4K |
1.1M |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vintage
|
93 |
22K |
1 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
93
|
22K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vintage
|
93 |
22K |
24 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
93
|
22K
|
24
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
vintage
|
279 |
83K |
9 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
279
|
83K
|
9
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
vintage
|
279 |
83K |
25 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
279
|
83K
|
25
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
vintage
|
279 |
83K |
5 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
279
|
83K
|
5
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
vintage
|
2.4K |
1.1M |
15 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
15
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
vintage
|
279 |
83K |
8 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
279
|
83K
|
8
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
vintage
|
279 |
83K |
16 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
279
|
83K
|
16
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
vintage
|
247 |
72K |
20 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
247
|
72K
|
20
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
vintage
|
247 |
72K |
5 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
247
|
72K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
vintage
|
279 |
83K |
6 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
279
|
83K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
vintage
|
247 |
72K |
11 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
247
|
72K
|
11
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
vintage
|
247 |
72K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
247
|
72K
|
1
|
|